PHASE II STUDY OF TUMOR-SPECIFIC IDIOTYPE AND SOLUBLE GM-CSF VACCINATION

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate the ability of Id-KLH and GM-CSF to induce cellular and humoral immune responses in patients with low-grade B-cell/mantle cell lymphoma following autologous stem cell transplantation. Evaluate the ability of Id-KLH and GM-CSF to induce or maintain complete clinical or molecular remission in patients with low-grade B-cell/mantle cell lymphoma following autologous stem cell transplantation